Regulus Resources Inc (REG) Fair Value & Analysis
Healthcare · CA · Market cap A$1.9B
Fair value as of: Jun 24, 2026
From 22 valuation models · updated 5 days ago
Share price −1.1% over the past month.
Price vs Fair Value (12 months)
12‑month range A$5.49 – A$8.73 · fair‑value band A$2.67 – A$4.45 · the A$6.25 price screens above the A$3.56 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Regulus Resources Inc (REG) currently trades at A$6.25, while our model-based Fair Value estimate is A$3.56 — implying the stock looks roughly 43.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Regulus Resources Inc generated revenue of A$1.3B at a net margin of 3.0%. Revenue grew 18.4% year over year. The balance sheet holds a net cash position of A$187M. The stock trades on a trailing P/E of 51.7. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Regulus Resources Inc. operates as a mineral exploration company in Canada and Peru. Its project include AntaKori copper-gold-silver project located in the Yanacocha-Hualgayoc mining district in the Department of Cajamarca, Northern Peru. The company was incorporated in 2010 and is headquartered in Vancouver, Canada.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Regulus Resources Inc reported revenue of A$1.2B in FY2025 versus A$686M in FY2021, a compound +13.9%/yr. Reported net income was A$49.0M in FY2025, compounding +25.2%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| 5225 5225 | 8.71 MYR | 4.87 MYR | -44% |
| IHHHF IHHHF | $1.71 | $0.7400 | -57% |
| Tenet Healthcare Corporation THC | $162.06 | $282.55 | +74% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.76 | R$30.33 | -7% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Regulus Resources Inc (REG) undervalued?
What is the fair value of REG?
What is the quality score of REG?
What is the revenue of Regulus Resources Inc (REG)?
What is the net profit margin of REG?
Does Regulus Resources Inc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.